The Affera system, with its globular Sphere-9 catheter, was acquired by Medtronic in August 2022 through its $925 million purchase of the device’s eponymous developer. Not long thereafter ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

Medtronic’s single-shot Pulseselect system became the first FDA-approved PFA device in December 2023, but it lacks mapping capabilities or the option to deliver RF energy from the catheter. Affera ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

aiming to characterize the role of Reveal LINQ ILR (Medtronic Inc., Minneapolis, MN) in the patient care pathway. 14 The study was designed and conducted in accordance with the Declaration of Helsinki ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The Simulus ® Adjustable Annuloplasty Ring and Band are fully flexible and enable finite adjustments. Based on preference and patient need, surgeons can choose between the Simulus Adjustable ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

The 'goal progress' cells therefore effectively act as flexible building blocks that come together to build a behavioral coordinate system," said Dr. El Gaby. In effect, the team found that the ...